Simulations Plus (SLP) EBITDA (2010 - 2026)
Simulations Plus (SLP) EBITDA from Nov 30, 2010 to May 31, 2026. The TTM Simulations Plus (SLP) EBITDA is $19M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Simulations Plus (SLP) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +7.13% |
| 5 Years TTM | +9.65% |
| 10 Years TTM | +7.61% |
| All Time TTM | +11.88% |
Annual EBITDA change of Simulations Plus (SLP)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $10M | -116.52% |
| 2025 | -$63M | -629.83% |
| 2024 | $12M | -6.13% |
| 2023 | $13M | -32.02% |
| 2022 | $18M | +24.60% |
| 2021 | $15M | +1.85% |
| 2020 | $15M | +607.28% |
| 2019 | $2.06M | +33.77% |
| 2018 | $1.54M | -10.47% |
| 2017 | $1.72M | +26.47% |
| 2016 | $1.36M | +22.52% |
| 2015 | $1.11M | -75.28% |
| 2014 | $4.49M | +9.25% |
| 2013 | $4.11M | +12.60% |
| 2012 | $3.65M | +2.82% |
| 2011 | $3.55M | +332.93% |
| 2010 | $820K | N/A |
Comparison Simulations Plus (SLP) five years EBITDA CAGR with competitors
Simulations Plus (SLP) five years EBITDA CAGR is 2.64%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| OPRX | OptimizeRx Corp | 77.72% | +2843.58% |
| CCLD | CareCloud Inc | 73.90% | +2698.71% |
| CCLDO | CareCloud Inc | 73.90% | +2698.71% |
| SY | So-Young International Inc | 39.98% | +1414.08% |
| DOCS | Doximity Inc - Class A | 32.10% | +1115.70% |
| HQY | Healthequity Inc | 28.20% | +968.06% |
| VEEV | Veeva Systems Inc - Class A | 23.79% | +801.02% |
| HCAT | Health Catalyst Inc | 20.13% | +662.55% |
| SDGR | Schrodinger Inc | 18.03% | +582.92% |
| PRVA | Privia Health Group Inc | 10.68% | +304.31% |
| EVH | Evolent Health Inc - Class A | 9.64% | +265.00% |
| SOPH | SOPHiA Genetics SA | 9.32% | +252.93% |
| HSTM | Healthstream Inc | 9.04% | +242.29% |
| OMCL | Omnicell Inc | 0.63% | -76.21% |
| DRIO | DarioHealth Corp | 0.22% | -91.70% |